According to the current analysis of Emergen Research, the global Active Psoriatic Arthritis Market was valued at USD 7.15 billion in 2019 and is expected to reach USD 13.64 billion by 2027, at a CAGR of 9.2%.Psoriatic arthritis is a chronic inflammatory disease that occurs in individuals suffering from psoriasis
According to the current analysis of Emergen Research, the global Active Psoriatic Arthritis Market was valued at USD 7.15 billion in 2019 and is expected to reach USD 13.64 billion by 2027, at a CAGR of 9.2%.Psoriatic arthritis is a chronic inflammatory disease that occurs in individuals suffering from psoriasis. It is a condition that leads to swelling and pain in the joints and can also affect the tendons and ligaments. In some cases, psoriatic arthritis can also lead to deformity of the joints. The exact cause of psoriasis is not known, but it is believed to be caused by a combination of genetic and environmental factors. Some of the symptoms associated with psoriatic arthritis include stiffness, pain, and swelling in the joints. The disease can also cause fatigue and loss of energy.
The rising prevalence of psoriasis is one of the key factors driving the growth of the active psoriatic arthritis market. According to the National Psoriasis Foundation, it is estimated that around 7.5 million people in the United States suffer from psoriasis. In addition, according to the World Health Organization, psoriasis affects 2-3% of the global population. The rising awareness about the disease and the availability of effective treatments are some of the other factors driving the growth of the market. However, the high cost of treatment is expected to restraint the growth of the market over the forecast period.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/72
Significant growth in incidences of active psoriatic arthritis is observed across emerging countries of Asia Pacific. According to the National Health and Nutrition Examination Survey (NHANES), the age-adjusted prevalence of arthritis was 22.7% in 2009-2010 in U.S…The psoriatic arthritis market is expected to grow on account of increasing number of pipeline molecules for the treatment of this condition. In addition, increasing number of clinical trials for the development of biologic agents is projected to provide significant growth opportunities for market players in the coming years. However, high cost associated with the treatment and lack of awareness about this disease are some major factors that may hamper the growth of the psoriatic arthritis market during the forecast period.
Key Highlights from the Report
- On the basis of drug class, the market is segmented into biologics, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and others. The biologics segment is expected to grow at the highest CAGR over the forecast period. This is attributed to the efficacy of biologic drugs in the treatment of psoriatic arthritis.
- The biologic segment is expected to grow at the highest CAGR over the forecast period due to the increasing use of biologics in the treatment of psoriatic arthritis. Biologic agents target specific parts of the immune system and have fewer side effects than other arthritis treatments.
- The hospital pharmacies segment is expected to grow at the highest CAGR over the forecast period. Hospital pharmacies are well-equipped with the latest technologies and have a team of experienced pharmacists who can advise patients on the use of psoriatic arthritis medications.
- The market for injectable therapies is growing due to the availability of various biologic approved agents. According to the National Psoriasis Foundation, approximately 30% of people with psoriasis also develop psoriatic arthritis, which is a form of inflammatory arthritis that affects the joints and tendons. Various treatments are available in the market for active psoriatic arthritis, which include biologics, small molecules, and others.
- North America is expected to hold the largest share in the global active psoriatic arthritis market over the forecast period. This is attributed to the rising prevalence of psoriasis, the availability of effective treatments, and the presence of a large number of key players in the region.
- The Asia Pacific region is expected to be the fastest-growing market for active psoriatic arthritis during the forecast period. The high growth of this region can be attributed to factors such as growing awareness about disease and its management, availability of treatment options, and increasing number of biopharmaceutical and pharmaceutical companies in the region.
- Key market players profiled for this industry analysis include Novartis International AG, Johnson & Johnson Services, AbbVie, AstraZeneca, Amgen, Celgene Corporation, Bristol-Myers Squibb Company, Bausch Health Companies, Eli Lilly and Company and Pfizer among other companies.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/active-psoriatic-arthritis-market
Emergen research have segmented Active Psoriatic Arthritis Market on the basis of product, drug class, route of administration and region:
Product Outlook (Revenue in Million USD; 2017–2027)
- Prescriptions
- OTC
- Other
Drug Class Outlook (Revenue in Million USD; 2017–2027)
- Biologics
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
- Other
By Route of Administration (Revenue in Million USD; 2017–2027)
- Injectable
- Oral
- Topical
Regional Outlook (Revenue in Million USD; 2017–2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
- Brazil
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/72
Explore More Reports Emergen Research:
Predictive and Prescriptive Analytics Market
Automotive Regenerative Braking System Market
Electric Vehicle Fast Charging System Market
Clinical Decision Support Systems Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-active-psoriatic-arthritis-market